The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.6004/jnccn.2020.0012 | DOI Listing |
Publication Analysis
Top Keywords
nccn guidelines
12
management immunotherapy-related
12
immunotherapy-related toxicities
12
guidelines insights
8
nccn
4
management
4
insights management
4
toxicities version
4
version 12020
4
12020 nccn
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!